Sign in

CIK 0001593899

  • Non-accelerated filer
  • Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
460574869
Phone
+1 857-284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 Berman Howard Director Grant or award · Restricted Stock Units +26,700 26,700
2026-06-18 Berman Howard Director Grant or award · Stock Option (Right to Buy) +37,700 37,700
2025-06-20 Berman Howard Director Grant or award · Stock Option (Right to Buy) +164,800 164,800

Page 1 of 1 · 3 trades